4/14
08:00 am
anix
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Medium
Report
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
4/10
08:48 am
anix
Anixa Biosciences, Inc. (NASDAQ: ANIX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
Low
Report
Anixa Biosciences, Inc. (NASDAQ: ANIX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
4/9
08:31 am
anix
EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent [Yahoo! Finance]
High
Report
EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent [Yahoo! Finance]
4/9
08:27 am
anix
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology [Yahoo! Finance]
Medium
Report
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology [Yahoo! Finance]
4/9
08:00 am
anix
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Medium
Report
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
4/1
08:00 am
anix
Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
Medium
Report
Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
3/26
08:19 am
anix
Anixa Biosciences, Inc. (NASDAQ: ANIX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
Medium
Report
Anixa Biosciences, Inc. (NASDAQ: ANIX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
3/25
08:27 am
anix
Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines [Yahoo! Finance]
Medium
Report
Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines [Yahoo! Finance]
3/25
08:17 am
anix
Anixa Biosciences, Inc. (NASDAQ: ANIX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Medium
Report
Anixa Biosciences, Inc. (NASDAQ: ANIX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
3/25
08:00 am
anix
Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines
Medium
Report
Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines
3/24
08:35 am
anix
Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine [Yahoo! Finance]
Low
Report
Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine [Yahoo! Finance]
3/24
08:00 am
anix
Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine
Medium
Report
Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine
3/21
08:15 am
anix
Anixa Biosciences, Inc. (NASDAQ: ANIX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.
Low
Report
Anixa Biosciences, Inc. (NASDAQ: ANIX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.
3/21
08:15 am
anix
Anixa Biosciences, Inc. (NASDAQ: ANIX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.
Low
Report
Anixa Biosciences, Inc. (NASDAQ: ANIX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.
3/17
08:00 am
anix
Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th
Medium
Report
Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th
3/10
08:30 am
anix
Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Medium
Report
Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
3/3
08:06 am
anix
Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th [Yahoo! Finance]
Medium
Report
Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th [Yahoo! Finance]
3/3
08:00 am
anix
Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th
Medium
Report
Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th
2/26
08:21 am
anix
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial [Yahoo! Finance]
Low
Report
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial [Yahoo! Finance]
2/26
08:00 am
anix
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
Low
Report
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
2/25
07:55 am
anix
Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports" [Yahoo! Finance]
Low
Report
Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports" [Yahoo! Finance]
2/25
07:30 am
anix
Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"
Low
Report
Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"
2/24
08:08 am
anix
Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer [Yahoo! Finance]
Medium
Report
Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer [Yahoo! Finance]
2/24
08:00 am
anix
Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer
Medium
Report
Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer
2/18
04:03 pm
anix
Anixa Biosciences, Inc. (NASDAQ: ANIX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Medium
Report
Anixa Biosciences, Inc. (NASDAQ: ANIX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.